The authors propose to report progress on the use of the CA 125 serum assay. It affects three situations: screening, diagnosis and the follow-up of the patients dealt with ovarian tumour either of benign or malignant nature. For each situation the interest and the relevance of CA 125 assay will be approached.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.gyobfe.2006.01.026 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!